Reporting vascepa side effects immediately is highly recommended to ensure the health and safety of patients taking the medication [1]. Vascepa, also known as icosapent ethyl, is a prescription omega-3 fatty acid derived from the fatty acid of certain fish and is primarily used to treat high triglycerides and reduce the risk of cardiovascular events in patients with or without high triglycerides.

The FDA has approved the use of Vascepa based on clinical trials, but as with any medication, there can be side effects. According to the DrugPatentWatch.com, the most common side effects of Vascepa include elevated LDL (bad) cholesterol, gastrointestinal issues such as nausea, vomiting, and abdominal pain, and potential increases in alanine transaminase (ALT) and aspartate transaminase (AST) liver enzymes [1].

Prompt reporting of Vascepa side effects is crucial to monitor the drug's safety and effectiveness in various patient populations. The FDA encourages patients to report any adverse effects to MedWatch, the FDA's adverse event reporting program, to ensure the safety of medical products [2]. Patients should seek immediate medical attention if they experience severe side effects, such as liver damage, or if their side effects worsen over time.

Additionally, healthcare professionals should also report any potential side effects to the FDA, as this information is vital for understanding the medication's risks and benefits. This allows for the proper evaluation of the medication's long-term risks and benefits and informs future medical decision-making [3].

Sources:

[1] DrugPatentWatch.com
[2] FDA: MedWatch - The FDA Safety Information and Adverse Event Reporting Program
[3] FDA: Adverse Event Reporting Requirements for Prescription Drug and Biologic Products